{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:51:37Z","timestamp":1781621497364,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multisystem inflammatory syndrome in children (MIS-C) has been identified as a systemic inflammatory disorder complicating Coronavirus Disease 2019 (COVID-19) in children. Three different definition criteria have been proposed including clinical and laboratory features. MIS-C has variable presentation, severity and outcome. This study aimed to describe the clinic-laboratory and imaging features of MIS-C among Egyptian pediatric patients, as well as the treatment and outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This was a retrospective observational study that included 142 MIS-C patients who were admitted at Children\u2019s Hospital, Ain Shams University during the period from June 8, 2020, to January 26, 2022. Diagnosis of MIS-C followed CDC criteria. The medical records of the patients were reviewed for age, gender, initial presentation, interval time since COVID-19 infection or contact with COVID-19 patient, course of the disease, blood picture, acute phase reactants, kidney and liver function tests, imaging studies mainly echocardiogram and magnetic resonance imaging of the brain, therapeutic lines and outcome).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age varied from 4.5 years (4th wave) to 9 years (2nd wave). PCR positivity declined from 61% (1st wave) to 0% (4th wave), with lower IgG and higher IgM levels in the 1st wave (p\u2009&lt;\u20090.001). Fever was universal (100%), Gastrointestinal symptoms were more common in the 1st wave (p\u2009=\u20090.005), whereas respiratory and neurological symptoms rose in later waves (p\u2009&lt;\u20090.05). Lymphopenia and thrombocytopenia varied across waves (p\u2009&lt;\u20090.01), with elevated inflammatory markers consistent throughout. Cardiac involvement, particularly coronary abnormalities, was highest in the 1st wave (p\u2009=\u20090.005). Treatment included IVIG and steroids, with increased use of pulse steroids and anti-IL1 therapy in later waves (p\u2009=\u20090.001). Hospital stays shortened from 10 days (2nd wave) to 3.5 days (4th wave), and mortality was highest in the 1st wave (9.4%). Conclusion: MIS-C cases in our center showed a consistent 2\u20137 weeks lag after COVID-19 peaks, with variable clinical and treatment trends. Improved outcomes over time, including shorter hospital stays and lower mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-025-06350-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:53:59Z","timestamp":1764068039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cCharacteristics of children with multisystem inflammatory syndrome in children during different COVID-19 waves \u201cSingle centre Study\u201d"],"prefix":"10.1186","volume":"25","author":[{"given":"Hanan M.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa","family":"kotby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"El-Ghoneimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin G.","family":"El Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Tomom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Rezk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa W.","family":"Abdelhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelwahab","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Noshey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-7799","authenticated-orcid":false,"given":"Sondos M.","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"6350_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12519-020-00392-y","volume":"17","author":"R Sinaei","year":"2021","unstructured":"Sinaei R, Pezeshki S, Parvaresh S, Sinaei R. Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr. 2021;17(1):10\u201320.","journal-title":"World J Pediatr"},{"issue":"7","key":"6350_CR2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00431-021-03993-5","volume":"180","author":"L Hoste","year":"2021","unstructured":"Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180(7):2019\u201334.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"6350_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jmii.2023.01.001","volume":"56","author":"PI Lee","year":"2023","unstructured":"Lee PI, Hsueh PR. Multisystem inflammatory syndrome in children: a dysregulated autoimmune disorder following COVID-19. J Microbiol Immunol Infect. 2023;56(2):236\u201345. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.001.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"6350_CR4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063259","volume":"153","author":"M Day-Lewis","year":"2024","unstructured":"Day-Lewis M, Berbert L, Baker A, Dionne A, Newburger JW, Son MBF. Updated case definition of MIS-C and implications for clinical care. Pediatrics. 2024;153(2):e2023063259. https:\/\/doi.org\/10.1542\/peds.2023-063259.","journal-title":"Pediatrics"},{"issue":"22","key":"6350_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226806","volume":"11","author":"L Stopyra","year":"2022","unstructured":"Stopyra L, Kowalik A, Stala J, Majchrzak I, Szebla J, Jakosz M, et al. Characteristics of hospitalized pediatric patients in the first five waves of the COVID-19 pandemic in a single center in Poland: 1407 cases. J Clin Med. 2022;11(22):6806. https:\/\/doi.org\/10.3390\/jcm11226806.","journal-title":"J Clin Med"},{"issue":"4","key":"6350_CR6","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00431-022-04790-4","volume":"182","author":"K Ptak","year":"2023","unstructured":"Ptak K, Szymo\u0144ska I, Olchawa-Czech A, Kukla K, Cisowska M, Kwinta P. Comparison of the course of multisystem inflammatory syndrome in children during different pandemic waves. Eur J Pediatr. 2023;182(4):1647\u201356. https:\/\/doi.org\/10.1007\/s00431-022-04790-4.","journal-title":"Eur J Pediatr"},{"key":"6350_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/2333794X21990339","volume":"8","author":"S Mahmoud","year":"2021","unstructured":"Mahmoud S, Fouda EM, Kotby A, Ibrahim HM, Gamal M, El Gendy YG, et al. The golden hours algorithm for the management of the multisystem inflammatory syndrome in children (MIS-C). Glob Pediatr Health. 2021;8:2333794X21990339. https:\/\/doi.org\/10.1177\/2333794X21990339.","journal-title":"Glob Pediatr Health"},{"key":"6350_CR8","unstructured":"-Children\u2019s Minnesota. MIS-C Clinical Guideline [Internet]. Minneapolis (MN): Children\u2019s Minnesota; 2024 [cited 2025 Sep 14]. Available from: https:\/\/www.childrensmn.org\/departments\/infectioncontrol\/pdf\/mis-c-clinical-guideline.pdf"},{"issue":"4","key":"6350_CR9","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1002\/art.41616","volume":"73","author":"LA Henderson","year":"2021","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. 2021;73(4):e13-29. https:\/\/doi.org\/10.1002\/art.41616.","journal-title":"Arthritis Rheumatol"},{"key":"6350_CR10","unstructured":"Chapter -Maine, American Academy of Pediatrics. ; Barbara Bush Children\u2019s Hospital, Maine Medical Center. MULTISYSTEM INFLAMMATORY SYNDROME in CHILDREN (MIS-C) Associated with COVID-19 \u2013 Clinical Practice Guideline [Internet]. Portland (ME): Maine AAP; 2022 Feb 28 [cited 2025 Sep 14]. Available from: https:\/\/www.maineaap.org\/assets\/resources\/Pediatric-Clinical-Guideline-MIS-C-updated-2.28.2022.pdf"},{"issue":"6","key":"6350_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00430-023-00783-8","volume":"212","author":"R Emad","year":"2023","unstructured":"Emad R, Naga IS. Comparative genotyping of SARS-CoV-2 among Egyptian patients: near-full length genomic sequences versus selected Spike and nucleocapsid regions. Med Microbiol Immunol. 2023;212(6):437\u201346. https:\/\/doi.org\/10.1007\/s00430-023-00783-8.","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"6350_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12879-023-08527-y","volume":"23","author":"A -Kandeel","year":"2023","unstructured":"-Kandeel A, Moatasim Y, Fahim M, Bahaaeldin H, El-Shesheny R, Roshdy WH, et al. Comparison of SARS-CoV-2 Omicron variant with the previously identified SARS-CoV-2 variants in Egypt, 2020\u20132022: insight into genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality. BMC Infect Dis. 2023;23(1):542. https:\/\/doi.org\/10.1186\/s12879-023-08527-y. PMID: 37596534; PMCID: PMC10439637.","journal-title":"BMC Infect Dis"},{"issue":"24","key":"6350_CR13","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1001\/jama.2022.8025","volume":"327","author":"N -Levy","year":"2022","unstructured":"-Levy N, Koppel JH, Kaplan O, Yechiam H, Shahar-Nissan K, Cohen NK, et al. Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA. 2022;327(24):2452\u20134. PMID: 35588048; PMCID: PMC9121298.","journal-title":"JAMA"},{"issue":"6","key":"6350_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-025-06153-1","volume":"184","author":"T Carzaniga","year":"2025","unstructured":"Carzaniga T, Calcaterra V, Casiraghi L, Inzani T, Carelli S, Del Castillo G, et al. Dynamics of Multisystem Inflammatory Syndrome in Children (MIS-C) associated to COVID-19: steady severity despite declining cases and new SARS-CoV-2 variants\u2014a single-center cohort study. Eur J Pediatr. 2025;184(6):327. https:\/\/doi.org\/10.1007\/s00431-025-06153-1.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"6350_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2021680.","journal-title":"N Engl J Med"},{"issue":"1","key":"6350_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2023-002344","volume":"8","author":"Q Abbas","year":"2024","unstructured":"Abbas Q, Ali H, Amjad F, Hussain MZH, Rahman AR, Khan MH, et al. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review. BMJ Paediatr Open. 2024;8(1):e002344. https:\/\/doi.org\/10.1136\/bmjpo-2023-002344.","journal-title":"BMJ Paediatr Open"},{"issue":"6","key":"6350_CR17","doi-asserted-by":"publisher","first-page":"e2116420","DOI":"10.1001\/jamanetworkopen.2021.16420","volume":"4","author":"AB -Payne","year":"2021","unstructured":"-Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR, Patel MS, et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open. 2021;4(6):e2116420. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.16420.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6350_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","volume":"22","author":"SP Weisberg","year":"2021","unstructured":"Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021;22(1):25\u201331. https:\/\/doi.org\/10.1038\/s41590-020-00826-9.","journal-title":"Nat Immunol"},{"issue":"4","key":"6350_CR19","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.1212\/NXI.0000000000000999","volume":"8","author":"M -Sa","year":"2021","unstructured":"-Sa M, Mirza L, Carter M, Carlton Jones L, Gowda V, Handforth J, et al. Systemic inflammation is associated with neurologic involvement in pediatric inflammatory multisystem syndrome associated with SARS-CoV-2. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e999. PMID: 33850037; PMCID: PMC8054962.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"6350_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaneurol.2021.0504","volume":"78","author":"KL -LaRovere","year":"2021","unstructured":"-LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. Neurologic involvement in children and adolescents hospitalized in the united States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78(5):536\u201347. PMID: 33666649; PMCID: PMC7936352.","journal-title":"JAMA Neurol"},{"key":"6350_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.003","volume":"226","author":"JY -Abrams","year":"2020","unstructured":"-Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J Pediatr. 2020;226:45\u2013e541. PMID: 32768466; PMCID: PMC7403869.","journal-title":"J Pediatr"},{"key":"6350_CR22","doi-asserted-by":"crossref","unstructured":"-Nofech-Mozes Y, Garty BZ. Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms. Pediatr Hematol Oncol. 2003;20(8):597\u2013601. doi: 10.1080\/08880010390241941. PMID: 14578029.","DOI":"10.1080\/08880010390243004"},{"key":"6350_CR23","unstructured":"-Council of State and Territorial Epidemiologists; Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C): 2023 surveillance case definition [Internet]. Atlanta (GA): CDC; 2023 [cited 2025 Sep 14]. Available from: https:\/\/ndc.services.cdc.gov\/case-definitions\/multisystem-inflammatory-syndrome-in-children-mis-c-2023\/"},{"issue":"2","key":"6350_CR24","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.119001","volume":"32","author":"A Karimi","year":"2022","unstructured":"Karimi A, Ghafouri P, Alilou S, Rezaei N, Ashraf Talesh S, Ashraf H. Echocardiographic findings in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: a systematic review. Int J Pediatr. 2022;32(2):e119001. https:\/\/doi.org\/10.5812\/ijp.119001.","journal-title":"Int J Pediatr"},{"issue":"4","key":"6350_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4):347\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2021756.","journal-title":"N Engl J Med"},{"issue":"1","key":"6350_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2102605","volume":"385","author":"MBF Son","year":"2021","unstructured":"Son MBF, Murray N, Friedman K, Young CC, Newhams MM, Feldstein LR, et al. Multisystem inflammatory syndrome in children: initial therapy and outcomes. N Engl J Med. 2021;385(1):23\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2102605.","journal-title":"N Engl J Med"},{"issue":"11","key":"6350_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/art.41454","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020;72(11):1791\u2013805. https:\/\/doi.org\/10.1002\/art.41454.","journal-title":"Arthritis Rheumatol"},{"key":"6350_CR28","unstructured":"-Children\u2019s Reference Ranges for FBC. Q pulse reference no: HA\/WE\/003. Version 4. Authorised by: Paul Virgo."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06350-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06350-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06350-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:53:54Z","timestamp":1781618034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06350-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6350"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06350-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the parents or caregivers of patients before enrolment in the study. The study was approved by the research ethical committee of Ain-Shams University, Faculty of Medicine (FMASU), The FMASU REC is organized and operated according to guidelines of the International Council on Harmonization (ICH) and the Islamic Organization for Medical Sciences (IOMS), the United States Office for Human Research Protections and the United States Code of Federal Regulations and operates under Federal Wide Assurance No. FWA 000017585. and was conducted in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from the parents or legal guardians of all participants before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent for publication of the patient\u2019s clinical details was obtained from the parents or caregivers of patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"988"}}